Drugs / Antihemophilic Factor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06764927 Comparator | Jan → Mar 2026 | — | Ezeldeen Abuelkasem | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antihemophilic Factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06764927 ↗ |
| Known as | AHF | “Cryoprecipitate Antihemophilic Factor (AHF), also known as cryo, is a frozen blood product prepared from blood plasma.” NCT06764927 ↗ |
| Known as | cryo | “Cryoprecipitate Antihemophilic Factor (AHF), also known as cryo, is a frozen blood product prepared from blood plasma.” NCT06764927 ↗ |